[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100351255":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":21,"locations":31,"responsibleParty":80,"collaborators":10,"id":84,"slug":10,"hasResults":85,"nctId":86,"briefTitle":87,"officialTitle":88,"acronym":10,"eligibilityCriteria":89,"healthyVolunteers":85,"sex":90,"minAge":91,"maxAge":92,"enrollmentInfo":93,"targetDuration":10,"studyType":96,"phases":10,"briefSummary":97,"conditions":98,"keywords":10,"overallStatus":34,"whyStopped":10,"lastUpdateSubmitDate":105,"lastUpdatePostDateStruct":106,"startDateStruct":109,"completionDateStruct":111,"leadSponsor":113,"locationsCount":114},{"fullName":5,"class":6},"Copenhagen University Hospital, Hvidovre","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Diagnostic imaging",null,"The progression of fibrosis will be assessed based on diagnostic imaging of thre subgroups including\n\nPatients with chronic pancreatitis (CP; N=50) of any aetiology, except gallstones, based on MANNHEIM.\n\nPatients with their first attack of acute pancreatitis (AP; N=50) of any aetiology except gallstones using the revised Atlanta criteria for AP.\n\nPatients with recurrent AP (RAP; N=50) except gallstones, defined as two or more cases of AP as diagnosed by the revised Atlanta Criteria.",[13],"Diagnostic Test: Diagnostic imaging",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":19},"DIAGNOSTIC_TEST","MRI assessments including magnetic resonance cholangiopancreatography (MRCP) and diffusion weighted imaging (DWI) combined with gold standard EUS",[9],[20],"MRI and EUS",[22,27],{"name":23,"role":24,"phone":25,"phoneExt":10,"email":26},"Srdan Novovic, PhD","CONTACT","38623862","srdan.novovic@regionh.dk",{"name":28,"role":24,"phone":29,"phoneExt":10,"email":30},"Lise L Gluud, MSc","+45 38621964","lise.lotte.gluud.01@regionh.dk",[32,52,66],{"facility":33,"status":34,"city":35,"state":36,"zip":37,"country":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"Gastrounit, Copenhagen University Hospital Hvidovre","RECRUITING","Hvidovre","Capital Region Denmark","2650","Denmark",{"type":40,"coordinates":41},"Point",[42,43],12.47708,55.64297,{"lat":43,"lon":42},[46,49],{"name":47,"role":24,"phone":48,"phoneExt":10,"email":30},"Lise L Gluud, MD","+4538621964",{"name":50,"role":24,"phone":51,"phoneExt":10,"email":26},"Srdan Novovic, MD","+38623862",{"facility":53,"status":34,"city":54,"state":10,"zip":55,"country":38,"cosmosGeoPoint":56,"geoPoint":60,"contacts":61},"Department of Gastroenterology & Hepatology, Aalborg University Hospital","Aalborg","9000",{"type":40,"coordinates":57},[58,59],9.9187,57.048,{"lat":59,"lon":58},[62],{"name":63,"role":24,"phone":64,"phoneExt":10,"email":65},"Soeren Schou Olesen, PhD","+45 97 66 00 00","soso@dcm.aau.dk",{"facility":67,"status":34,"city":68,"state":10,"zip":69,"country":38,"cosmosGeoPoint":70,"geoPoint":74,"contacts":75},"Abdominal Centre, Bispebjerg University Hospital","Copenhagen","2200",{"type":40,"coordinates":71},[72,73],12.56553,55.67594,{"lat":73,"lon":72},[76],{"name":77,"role":24,"phone":78,"phoneExt":10,"email":79},"Lars Nannestad Joergensen, PhD","+45 21 32 02 41","lars.nannestad.joergensen@regionh.dk",{"type":81,"investigatorFullName":82,"investigatorTitle":83,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Lise Gluud","Associate Professor","100351255",false,"NCT03853447","Fibro-inflammatory Progression From Acute to Chronic Pancreatitis","Characterization of Fibro-inflammation During Progression From Acute to Chronic Pancreatitis","Inclusion Criteria:\n\n* Patients with CP (N=50) of any aetiology except gallstone induced CP: CP will be diagnosed based on MANNHEIM criteria .\n* Cohort 2: Patients with their first attack of AP of any aetiology except gallstone induced AP (N=50). The revised Atlanta criteria for acute pancreatitis will be used as diagnostic criteria.\n* Cohort 3: Patients with RAP (N=50) except gallstone induced RAP. RAP is defined as two or more cases of AP as diagnosed by the revised Atlanta Criteria.\n\nExclusion Criteria:","ALL","18 Years","70 Years",{"count":94,"type":95},150,"ESTIMATED","OBSERVATIONAL","Observational prospective study evaluating the developement of chronic pancreatitis based on imaging modalities as well as biochemical markers of inflammation, fibrosis and oxidative stress.",[99,100,101,102,103,104],"Pancreatitis","Acute Pancreatitis","Recurrent Pancreatitis","Chronic Pancreatitis","Inflammation","Fibrosis","2020-04-07",{"date":107,"type":108},"2020-04-08","ACTUAL",{"date":110,"type":108},"2019-02-14",{"date":112,"type":95},"2041-01-01",{"name":5,"class":6},3]